Bayer, DE000BAY0017

Bayer stock after-hours at EUR 45.27: minus 5.23 percent versus the prior close

Published on 10/01/2026 at 21:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer stock was at EUR 45.27 after-hours at 9:50 p.m. CEST on October 1, 2026, down 5.23 percent versus the prior close at Lang & Schwarz. Bayer appointed Christoph Koenen as chief medical officer.

Makrofotografie von weißen runden Tabletten in extremer Nahaufnahme
Bayer AG (DE000BAY0017): Makroaufnahme weißer runder Tabletten mit scharfer Tiefenschärfe und feiner Oberflächentextur, Illustration mit AI erstellt.

Bayer stock was at EUR 45.27 after-hours at 9:50 p.m. CEST on October 1, 2026, according to Lang & Schwarz. The price was down EUR 2.50, or 5.23 percent, versus the prior close of EUR 47.77.

Trading day in Frankfurt

The Lang & Schwarz quote showed a bid of EUR 45.21 and an ask of EUR 45.33. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Bayer stock.

Bayer appoints chief medical officer

Bayer announced on October 1, 2026, that Dr. Christoph Koenen had been appointed chief medical officer, effective the same day. He will lead medical and scientific strategies across the organization while continuing as head of clinical development and operations for Bayer’s Pharmaceuticals Division, according to the Bayer announcement.

Bayer said Koenen joined the company in 2022 and has more than 25 years of global pharmaceutical experience. The company also said it is advancing around 30 projects in clinical development. Koenen holds an MD from Ruprecht Karls University School of Medicine in Heidelberg and an MBA from Schiller International University, the company release said.

Disclaimer...

en | DE000BAY0017 | BAYER | boerse | 70213069 | bgmi